Skip to main content
NCBI home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1982 Apr 24;284(6324):1213–1215. doi: 10.1136/bmj.284.6324.1213

Influence of contraceptive pill and menstrual cycle on serum lipids and high-density lipoprotein cholesterol concentrations.

P N Demacker, R W Schade, A F Stalenhoef, P M Stuyt, A van't Laar
PMCID: PMC1498071  PMID: 6803905

Abstract

The fluctuations of serum lipid and lipoprotein concentrations within one cycle were studied both in women using and not using oral contraceptives. High-density lipoprotein cholesterol decreased significantly from 1.47 mmol/l (57 mg/100 ml) to 1.30 mmol/l (50 mg/100 ml) during one contraceptive cycle in eight women and rose again to the initial value during the pill-free days. The mean concentration of total cholesterol also fell significantly as a result of the decrease of high-density lipoprotein cholesterol and of a not significant decrease of low-density lipoprotein cholesterol. The mean serum triglyceride concentration did not change significantly. The fluctuations in the concentration of serum lipids and lipoproteins in 10 women not using oral contraceptives were smaller than in the women using oral contraceptives and no significant changes in the concentrations were found during one cycle. Thus, high-density lipoprotein cholesterol concentration decreases during each contraceptive cycle. The time of blood sampling during the cycle is, therefore, of vital importance in interpreting the effect of oral contraceptives on high-density lipoprotein cholesterol. In women not using oral contraceptives blood can be sampled on random days during the cycle.

Full text

PDF
1213

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ADLERCREUTZ H., TALLQVIST G. Variations in the serum total cholesterol and hematocrit values in normal women during the menstrualcycle. Scand J Clin Lab Invest. 1959;11:1–9. doi: 10.3109/00365515909060400. [DOI] [PubMed] [Google Scholar]
  2. Arntzenius A. C., van Gent C. M., van der Voort H., Stegerhoek C. I., Styblo K. Reduced high-density lipoprotein in women aged 40-41 using oral contraceptives. Consultation Bureau Heart Project. Lancet. 1978 Jun 10;1(8076):1221–1223. doi: 10.1016/s0140-6736(78)92461-3. [DOI] [PubMed] [Google Scholar]
  3. BARCLAY M., BARCLAY R. K., SKIPSKI V. P., TEREBUS-KEKISH O., MUELLER C. H., SHAH E., ELKINS W. L. FLUCTUATIONS IN HUMAN SERUM LIPOPROTEINS DURING THE NORMAL MENSTRUAL CYCLE. Biochem J. 1965 Jul;96:205–209. doi: 10.1042/bj0960205. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Beral V. Cardiovascular-disease mortality trends and oral-contraceptive use in young women. Lancet. 1976 Nov 13;2(7994):1047–1052. doi: 10.1016/s0140-6736(76)90966-1. [DOI] [PubMed] [Google Scholar]
  5. Bierenbaum M. L., Fleischman A. I., Stier A., Watson P., Somol H., Naso A. M., Binder M. Increased platelet aggregation and decreased high-density lipoprotein cholesterol in women on oral contraceptives. Am J Obstet Gynecol. 1979 Jul 15;134(6):638–641. doi: 10.1016/0002-9378(79)90644-6. [DOI] [PubMed] [Google Scholar]
  6. Bradley D. D., Wingerd J., Petitti D. B., Krauss R. M., Ramcharan S. Serum high-density-lipoprotein cholesterol in women using oral contraceptives, estrogens and progestins. N Engl J Med. 1978 Jul 6;299(1):17–20. doi: 10.1056/NEJM197807062990104. [DOI] [PubMed] [Google Scholar]
  7. DUBOFF G. S., STEVENSON W. W. An ultramicro method for the estimation of plasma cholesterol. Clin Chem. 1962 Apr;8:105–112. [PubMed] [Google Scholar]
  8. Demacker P. N., Hijmans A. G., van Sommeren-Zondag D. F., Jansen A. P. Stability of frozen liquid control sera for assay of cholesterol in high-density lipoprotein. Clin Chem. 1982 Jan;28(1):155–157. [PubMed] [Google Scholar]
  9. Demacker P. N., Vos-Janssen H. E., Hijmans A. G., van't Laar A., Jansen A. P. Measurement of high-density lipoprotein cholesterol in serum: comparison of six isolation methods combined with enzymic cholesterol analysis. Clin Chem. 1980 Dec;26(13):1780–1786. [PubMed] [Google Scholar]
  10. Friedewald W. T., Levy R. I., Fredrickson D. S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972 Jun;18(6):499–502. [PubMed] [Google Scholar]
  11. Hennekens C. H., Evans D. A., Castelli W. P., Taylor J. O., Rosner B., Kass E. H. Oral contraceptive use and fasting triglyceride, plasma cholesterol and HDL cholesterol. Circulation. 1979 Sep;60(3):486–489. doi: 10.1161/01.cir.60.3.486. [DOI] [PubMed] [Google Scholar]
  12. Kim H. J., Kalkhoff R. K. Changes in lipoprotein composition during the menstrual cycle. Metabolism. 1979 Jun;28(6):663–668. doi: 10.1016/0026-0495(79)90020-9. [DOI] [PubMed] [Google Scholar]
  13. Krauss R. M., Lindgren F. T., Silvers A., Jutagir R., Bradley D. D. Changes in serum high density lipoproteins in women on oral contraceptive drugs. Clin Chim Acta. 1977 Nov 1;80(3):465–470. doi: 10.1016/0009-8981(77)90139-5. [DOI] [PubMed] [Google Scholar]
  14. LEFFLER H. H., McDOUGALD C. H. Estimation of cholesterol in serum by means of improved technics. Tech Bull Regist Med Technol. 1963 Feb;33:19–23. [PubMed] [Google Scholar]
  15. Larsson-Cohn U., Wallentin L., Zador G. Effects of three different combinations of ethinyl estradiol and levonorgestrel on plasma lipids and high density lipoproteins. Acta Obstet Gynecol Scand Suppl. 1979;88:57–60. doi: 10.3109/00016347909157230. [DOI] [PubMed] [Google Scholar]
  16. Meerloo J. M., Billimoria J. D. High density lipoprotein cholesterole levels in peripheral vascular disease and in women on oral contraception. Atherosclerosis. 1979 Jun;33(2):267–269. doi: 10.1016/0021-9150(79)90124-2. [DOI] [PubMed] [Google Scholar]
  17. Rhoads G. G., Gulbrandsen C. L., Kagan A. Serum lipoproteins and coronary heart disease in a population study of Hawaii Japanese men. N Engl J Med. 1976 Feb 5;294(6):293–298. doi: 10.1056/NEJM197602052940601. [DOI] [PubMed] [Google Scholar]
  18. Rössner S., Frankman O., Marsk L. Effects of ethinylestradiol/D-norgestrel combinations on serum lipoproteins. Acta Obstet Gynecol Scand. 1980;59(3):255–258. doi: 10.3109/00016348009155406. [DOI] [PubMed] [Google Scholar]
  19. Schade R. W., Meuwese J. P., Thoben A. J., Demacker P. N. H.D.L. cholesterol during oral contraception. Lancet. 1978 Jul 1;2(8079):40–40. doi: 10.1016/s0140-6736(78)91343-0. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES